HQK-1001

· HemaQuest Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for HQK-1001, covering 2009-01-16 to 2015-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Effects of HQK-1001 in Patients With Sickle Cell Disease [Phase 2]